PHI announces significant order agreement from Altium for 20 HoloMonitor systems
Phase Holographic Imaging (PHI) is excited to announce a significant order agreement from Altium for 20 HoloMonitor systems, which will be shipped in the second half of 2024. The order agreement includes systems with various configurations and add-ons, which will impact the total order value.
"This order agreement from Altium is a testament to their strong confidence in the capability of HoloMonitor and its potential to meet market demands. Our collaboration with Altium has been influenced by an onboarding process and integration of new sales partners, which is starting to pay off as those systems will have a great contribution to our growth in the coming fiscal year", comments Patrik Eschricht, CEO of PHI.
The order agreement for 20 HoloMonitor units follows the distribution agreement that PHI’ entered with Altium in November 2023. As PHI’s global distribution partner, Altium has utilized its wide network to develop HoloMonitor's market presence further. Over the last year, Altium has subcontracted various resellers and opened up many new markets for PHI in countries such as Azerbaijan, Bosnia and Herzegovina, Croatia, Czechia, Denmark, Estonia, Finland, Iceland, Israel, Kosovo, Latvia, Lithuania, Montenegro, North Macedonia, Norway, Poland, Portugal, Romania, Serbia, Spain, Sweden, Türkiye, among several other strategic markets.
This large order agreement from Altium shows great confidence in the capabilities of HoloMonitor and is intended for resale to end customers. The final shipments from PHI to Altium will be made before the end of 2024.
"Compared to Q3 and Q4 2023/24, during which Altium ordered 10 systems, this agreement is double the order size. The developing sales volumes are higher than we could have managed in-house ourselves, so we are very pleased with this first year of our distribution partnership", adds Patrik Eschricht, CEO of PHI.
This disclosure contains information that Phase Holographic is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 16-09-2024 13:52 CET.
For additional information, please contact:
Lisa Bodily
E-mail: ir@phiab.com
Web: www.phiab.com – Live cell imaging & analysis
About PHI
Phase Holographic Imaging (PHI) is a medical technology company that develops and markets its non-invasive time-lapse imaging instruments for long-term quantitative analysis of living cells. The foundation of PHI’s current commercial HoloMonitor® products is Quantitative Phase Imaging (QPI) technology — an innovative approach to cell quality evaluation. QPI offers detailed analysis of cell characteristics without harming the cells, avoiding the limitations of traditional measurement methods. PHI is actively focusing on business development to expand from pre-clinical research to the clinical market and the emerging regenerative medicine field. PHI envisions transforming live cell analysis and establishing QPI as a standard for cell quality control, making future cell therapies safe, affordable, and accessible for patients. PHI is based in Lund, Sweden, Boston, MA and Winston-Salem, NC.